6617 fundamentals
An in-depth look to GONGWIN BIOPHARM HOLDINGS CO LTD operating, investing, and financing activities
6617 free cash flow for Q3 24 is -26.09 M TWD. For 2023, 6617 free cash flow was -111.7 M TWD and operating cash flow was -110.8 M TWD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM